Fellowship · Loma Linda, CA
Sponsored by Loma Linda University Health Education Consortium
Efficacy of GLP-1 Receptor Agonists in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
Journal of cardiac failure · 2025 · 55 citations · Dmitry Abramov
Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
Journal of the American College of Cardiology · 2024 · 89 citations · Dmitry Abramov
Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021.
JAMA cardiology · 2024 · 97 citations · Dmitry Abramov
Temporal Trends in Substance Use and Cardiovascular Disease-Related Mortality in the United States.
Journal of the American Heart Association · 2024 · 39 citations · Dmitry Abramov
Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study.
European journal of preventive cardiology · 2024 · 45 citations · Dmitry Abramov
Underlying and contributing causes of mortality from CDC WONDER-Insights for researchers.
American heart journal plus : cardiology research and practice · 2025 · 22 citations · Dmitry Abramov
Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases.
Journal of the National Medical Association · 2024 · 35 citations · Dmitry Abramov
Impact of sodium-glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus: a comprehensive review.
Cardiovascular diabetology · 2025 · 19 citations · Liset Stoletniy, Antoine Sakr